Double Issue #3 & #4: Peptides, Calcium, and Catching Up

We missed a week, so this one is a double. Two issues, two weeks of health news, in one send. Let’s catch up.

The week in health you might have missed.

On July 23 and 24, the FDA’s Pharmacy Compounding Advisory Committee will meet to decide whether seven peptides should be added back to the list of substances that compounding pharmacies are legally allowed to prepare. The seven are BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax, and Emideltide (DSIP). If you spend any time in the biohacking, longevity, or recovery world, you know those names. They are everywhere right now.

Here is the backstory most coverage skips.

In 2023 and 2024, the FDA removed 19 peptides from the list compounding pharmacies could legally make, citing concerns about immunogenicity, toxicity, and impurity. That move pushed a huge, growing market into a gray zone of research-only labels and overseas sourcing. Now, under RFK Jr. and the MAHA agenda, the agency is reconsidering. The advisory committee meeting is the first formal step toward potentially loosening those restrictions.

Why this is more complicated than it looks

There are two honest things to hold at the same time here.

First, the demand is real and the restrictions did not make it go away. People are taking these peptides regardless. Pushing them out of regulated compounding pharmacies did not stop use. It just moved sourcing to less accountable suppliers, many of them overseas, with no quality control. If the goal is safety, an unregulated gray market is the worst of both worlds.

Second, the evidence base is thin. These peptides are promoted as near cure-alls for injury recovery, gut health, sleep, and aging. The human clinical data does not come close to backing those claims yet. Wanting something and it actually working are not the same thing, and a lot of the marketing blurs that line on purpose.

The China angle nobody wants to say out loud

Here is the part that turns this from a health story into a political one. These peptides are manufactured predominantly in China. That puts the MAHA push to expand access on a direct collision course with the China hawks in the same party, who do not love a fast-growing American health trend that runs on a Chinese supply chain. This is a rare case where the wellness world and national-security politics are about to crash into each other in public.

The bottom line

This is worth watching closely, not because peptides are proven miracles, and not because they are dangerous junk, but because the decision will tell you how the new FDA actually balances access against evidence. Loosen the rules and you reward demand ahead of data. Keep them locked and you keep a real market in the shadows. Either way, the July meeting is the clearest test yet of what Make America Healthy Again means in practice.

If you use any of these, the only sane move right now is to know your source and know that the human evidence is still early.

Nestle just finished pulling every synthetic dye from its US products. On June 15, Nestle USA announced it had completely eliminated FD&C synthetic colors from its entire US food and beverage portfolio, finishing a year ahead of the federal 2027 target and delivering on a pledge it made in 2025. The last holdouts were Nesquik products that still relied on Red No. 3 and Red No. 40, now reformulated with color from natural sources. These companies do not spend money reformulating thousands of products over a trend. They do it because they can see consumer demand has already moved. Food Safety Magazine

The FDA’s plan to close the GRAS loophole is quietly slipping. Last issue covered the push to end self-affirmed GRAS, the rule that lets companies declare their own ingredients generally recognized as safe with no FDA review. Here is the update: the agency quietly revised its website to say it will now deliver those reforms by the end of 2027, a full year later than Kennedy originally promised. Industry groups have poured millions into fighting the change. The announcement is easy. The follow-through is where the lobbying money goes to work.

Scientists admit they have no idea what most of your food actually does to you. A piece published this week laid out a wild fact: the human diet delivers more than 26,000 distinct chemical compounds, and only about 150 of them are well studied. Researchers call the rest nutritional dark matter. A project called the Foodome has already mapped more than 130,000 food molecules. The takeaway is humility. When someone tells you a single nutrient or additive fully explains a health outcome, remember they are working with a tiny fraction of the picture.

Five-a-day might not be enough for your heart, and it depends what you pick. A study of more than 30,000 people in the US and UK, published in Food & Function, found that fewer than 20 percent of people hit the flavanol intake linked to lower cardiovascular risk, even many who ate the recommended five servings of fruit and vegetables a day. Flavanols are concentrated in foods like blackberries, plums, apples, cherries, green tea, and cocoa, and the research ties about 500 mg a day to a lower risk of dying from heart disease. The honest caveat: one of the study’s partners was Mars, the chocolate company, which has funded flavanol research for years. Variety beats volume.

FDA Peptide Decision Pits RFK Jr.’s MAHA Movement Against China Hawks, Foreign Policy

FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters, PBS News

Nestle USA eliminates artificial colors, ConfectioneryNews

RFK Jr.’s MAHA Agenda Starts to Unravel at FDA Over GRAS, The Daily Beast

Scientists say most of what’s in your food is still a mystery, ScienceDaily

Think you’re eating healthy? You may be missing this heart-protecting nutrient, ScienceDaily

Caught up and current. Here is what happened in health this week.

If you are over 50, there is a good chance a doctor has told you to take calcium and vitamin D to protect your bones. It is one of the most routine recommendations in all of medicine. A major review published June 15 in The BMJ just took a hard look at that advice and found it largely does not hold up.

Researchers in Canada pooled data from 69 randomized controlled trials covering 153,902 adults, comparing calcium, vitamin D, or both against placebo or no treatment. The result: little to no clinically meaningful reduction in fractures or falls for most older adults. Not for calcium alone. Not for vitamin D alone. Not for the combination. And this was not weak data. The vitamin D analysis (36 trials, 92,045 people) and the combination analysis (15 trials, 51,126 people) were rated high-certainty evidence.

Why this is a bigger deal than it sounds

This is not a fringe contrarian take. The authors, publishing in one of the most established medical journals in the world, concluded the evidence does not support routine supplementation with calcium or vitamin D to prevent fractures and falls, and said clinicians, guideline panels, and regulatory agencies should re-evaluate their general recommendations.

The recommendation is everywhere. Prescriptions for these supplements have been climbing for years. And one of the biggest evidence reviews ever assembled says the routine version of this advice is not backed by the data.

This is the pattern, not the exception

The Wellness Wire exists because official guidance and what the evidence actually shows drift apart more often than people are told, and the guidance is always slow to admit it. We saw it with saturated fat. We saw it with whole milk in schools. This is the same story wearing a different coat.

What actually works for bones, according to the same researchers

The linked editorial did not say give up. It said redirect your effort to what is proven: balance training, resistance exercise, and personalized fall-prevention programs. The thing that actually protects aging bones is loading them. Lifting, moving, and training balance beats a pill that the data says is doing close to nothing.

One real caveat: this is about routine supplementation in the general older population. People with diagnosed osteoporosis, certain bone disorders, or genuine deficiency are a different conversation, and the researchers said so. If you are in that group, do not change anything without talking to your doctor.

A common supplement ingredient was just linked to a shorter lifespan in men. A study of more than 270,000 people, published June 15 in Aging-US, found that men with genetically higher blood levels of the amino acid tyrosine had a shorter life expectancy, by roughly 0.91 years. No significant link showed up in women. The researchers used Mendelian randomization, which gets closer to cause and effect than a normal observational study, though it still does not prove causation outright. Tyrosine is sold all over the supplement aisle, packed into pre-workouts and focus stacks. More is not always better. Newsweek

Eight common food preservatives just got linked to high blood pressure and heart disease. A French study tracking 112,395 people for up to eight years, published in the European Heart Journal and widely covered this week, found that eight commonly used preservatives were tied to higher rates of hypertension and cardiovascular disease, with the highest consumers showing about a 29 percent greater risk of high blood pressure. These are the workhorse preservatives in everyday packaged food. The problem with ultra-processed food is not only the sugar and refined grains, it is the full stack of additives that come along for the ride. ScienceDaily

Ozempic may protect bones, which makes this week’s timing interesting. A real-world study reported June 16 found that people with type 2 diabetes on semaglutide (Ozempic, Wegovy) had fewer bone fractures, even though they lost more weight. That is notable because rapid weight loss usually costs you bone density. Pair it with this issue’s lead story and you get an honest picture of where bone protection is actually coming from these days, and it is not the calcium aisle. As always with GLP-1 research, this is observational, so treat it as a signal, not a verdict.

The food industry says it literally cannot reformulate fast enough. As companies race to strip dyes and additives to meet looming deadlines and shifting demand, industry coverage this week describes manufacturers struggling to keep pace. Read that as a win. A few years ago, cleaning up the ingredients was a fringe ask. Now it is moving faster than the largest food companies on earth can comfortably handle. The pressure is working.

Millions take calcium and vitamin D for stronger bones. A major review finds little benefit, ScienceDaily

High Tyrosine Levels Linked to Shorter Lifespan in Men, Aging-US

Common food preservatives linked to high blood pressure and heart disease, European Society of Cardiology

Researchers found 8 common food additives linked to high blood pressure and heart disease, ScienceDaily

Semaglutide linked to fewer bone fractures despite greater weight loss, ScienceDaily

Food reformulation: Can manufacturers keep pace with changing demands?, BakeryandSnacks

That’s it for this double issue. We are officially caught up. If someone forwarded this to you, you can subscribe at wellnesswirereport.com. If you found it useful, forward it to someone who still trusts the FDA.

Stay skeptical,

Carson

The Wellness Wire. Weekly health intelligence. Read more, trust less.